Literature DB >> 22856462

Assessing the existing information on the efficacy of bovine vaccination against Escherichia coli O157:H7--a systematic review and meta-analysis.

N P Varela1, P Dick, J Wilson.   

Abstract

The objective of this study was to conduct a systematic review and meta-analysis to evaluate the existing information on the efficacy of commercial vaccination to reduce the prevalence of Escherichia coli O157:H7 in weaned cattle in beef feedlot finishing systems under commercial conditions. Currently, only two commercial vaccines exist, and thus, only publications reporting the use of vaccines targeting type III secreted proteins and/or siderophore receptor and porin proteins (SRP) were considered relevant. A total of 18 studies reporting 45 comparisons were included in this review. Meta-analyses were conducted variously on (i) pre-harvest outcomes, (ii) at-harvest outcomes and (iii) both pre-harvest and at-harvest outcomes combined. Overall, efficacy of vaccination was consistently observed. Efficacy and homogeneity of the results was demonstrated for the two-dose regimen, allowing us to conclude with confidence that the two-dose approach is efficacious. For pre-harvest outcomes and two-dose regimens, the odds ratios (OR) were 0.53 (95% CI = 0.45-0.62) for the two vaccines combined and 0.49 (95% CI = 0.40-0.60) for vaccine targeting type III secreted proteins. The test for heterogeneity among studies yielded a Q test P = 0.354 for the two vaccines combined and Q test P = 0.269 for the vaccine targeting type III secreted proteins, indicating homogeneity in both cases. For pre- and at-harvest outcomes combined and two-dose regimens, the odds ratios (OR) were 0.52 (95% CI = 0.44-0.61) for the two vaccines combined and 0.45 (95% CI = 0.34-0.60) for vaccine targeting type III secreted proteins. The test for heterogeneity among studies yielded a Q test P = 0.134 for the two vaccines combined indicating homogeneity and Q test P = 0.089 for the vaccine targeting type III secreted proteins indicating heterogeneity. Based on this meta-analysis, bovine vaccination appears to be an effective approach to the pre-harvest control of E. coli O157:H7.
© 2012 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22856462     DOI: 10.1111/j.1863-2378.2012.01523.x

Source DB:  PubMed          Journal:  Zoonoses Public Health        ISSN: 1863-1959            Impact factor:   2.702


  16 in total

1.  Strain-dependent cellular immune responses in cattle following Escherichia coli O157:H7 colonization.

Authors:  Alexander Corbishley; Nur Indah Ahmad; Kirsty Hughes; Michael R Hutchings; Sean P McAteer; Timothy K Connelley; Helen Brown; David L Gally; Tom N McNeilly
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

Review 2.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.

Authors:  Miguel O'Ryan; Roberto Vidal; Felipe del Canto; Juan Carlos Salazar; David Montero
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Exploiting the power of OMICS approaches to produce E. coli O157 vaccines.

Authors:  Anjana Kalita; Mridul Kalita; Alfredo G Torres
Journal:  Gut Microbes       Date:  2014

Review 4.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae.

Authors:  Miguel O'Ryan; Roberto Vidal; Felipe del Canto; Juan Carlos Salazar; David Montero
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Protective efficacy and pharmacokinetics of human/mouse chimeric anti-Stx1 and anti-Stx2 antibodies in mice.

Authors:  Angela R Melton-Celsa; H M Carvalho; Claire Thuning-Roberson; A D O'Brien
Journal:  Clin Vaccine Immunol       Date:  2015-02-25

6.  Predicting the public health benefit of vaccinating cattle against Escherichia coli O157.

Authors:  Louise Matthews; Richard Reeve; David L Gally; J Chris Low; Mark E J Woolhouse; Sean P McAteer; Mary E Locking; Margo E Chase-Topping; Daniel T Haydon; Lesley J Allison; Mary F Hanson; George J Gunn; Stuart W J Reid
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

7.  Repeated Oral Vaccination of Cattle with Shiga Toxin-Negative Escherichia coli O157:H7 Reduces Carriage of Wild-Type E. coli O157:H7 after Challenge.

Authors:  Smriti Shringi; Haiqing Sheng; Carolyn J Hovde; Thomas E Besser; Andrew A Potter; Scott A Minnich
Journal:  Appl Environ Microbiol       Date:  2021-01-04       Impact factor: 4.792

8.  Comparative genomics and immunoinformatics approach for the identification of vaccine candidates for enterohemorrhagic Escherichia coli O157:H7.

Authors:  Víctor A García-Angulo; Anjana Kalita; Mridul Kalita; Luis Lozano; Alfredo G Torres
Journal:  Infect Immun       Date:  2014-03-04       Impact factor: 3.441

9.  'Super' or just 'above average'? Supershedders and the transmission of Escherichia coli O157:H7 among feedlot cattle.

Authors:  Simon E F Spencer; Thomas E Besser; Rowland N Cobbold; Nigel P French
Journal:  J R Soc Interface       Date:  2015-09-06       Impact factor: 4.118

10.  Intranasal co-administration of recombinant active fragment of Zonula occludens toxin and truncated recombinant EspB triggers potent systemic, mucosal immune responses and reduces span of E. coli O157:H7 fecal shedding in BALB/c mice.

Authors:  Aravind Shekar; Shylaja Ramlal; Joseph Kingston Jeyabalaji; Murali Harishchandra Sripathy
Journal:  Med Microbiol Immunol       Date:  2018-09-12       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.